Company news
2021-01-07
On June 18th, US Food & Drug Administration granted China’s Jiangsu Bioperfectus Technologies an Emergency Use Authorization for its COVID-19 Coronavirus Real-Time PCR Kit.
The authorization requires that all promotional materials for the polymerase-chain-reaction (PCR) test clearly state that the test has not been cleared or approved by the FDA and must be used only by authorized laboratories.
September is Gynecologic Cancer Awareness Month! Join us in raising awareness this month.
HPV semen infection, regardless of HPV type and exact location of the virions, significantly impairs spermatozoa’s progressive motility, morphology, and immotile sperm rate.
Today serves as a reminder to prioritize sexual health and foster positive attitudes toward consent.
Copyright © 2010-2022 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.
Tel: +86 021-5484 7326 Email: info@bioperfectus.com
